Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Free Cash Flow (2016 - 2025)

Cardiff Oncology (CRDF) has disclosed Free Cash Flow for 15 consecutive years, with -$6.7 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 34.55% to -$6.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$38.7 million through Dec 2025, down 2.58% year-over-year, with the annual reading at -$38.7 million for FY2025, 2.58% down from the prior year.
  • Free Cash Flow hit -$6.7 million in Q4 2025 for Cardiff Oncology, up from -$10.9 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$4.3 million in Q2 2021 to a low of -$13.7 million in Q1 2025.
  • Historically, Free Cash Flow has averaged -$8.2 million across 5 years, with a median of -$7.9 million in 2022.
  • Biggest five-year swings in Free Cash Flow: tumbled 77.09% in 2022 and later soared 34.55% in 2025.
  • Year by year, Free Cash Flow stood at -$7.3 million in 2021, then dropped by 19.09% to -$8.7 million in 2022, then rose by 17.77% to -$7.1 million in 2023, then crashed by 42.54% to -$10.2 million in 2024, then surged by 34.55% to -$6.7 million in 2025.
  • Business Quant data shows Free Cash Flow for CRDF at -$6.7 million in Q4 2025, -$10.9 million in Q3 2025, and -$7.5 million in Q2 2025.